Rising Trend of Teenagers Using E-cigarettes in Vietnam

Regulations by 2FIRSTS.ai
Dec.07.2023
Rising Trend of Teenagers Using E-cigarettes in Vietnam
According to Vietnamese media, an increasing number of students are using e-cigarettes, despite health concerns.

According to recent reports by Vietnamese media, local government officials have observed a concerning trend of young teenagers wearing school uniforms while openly smoking e-cigarettes. The scene is often marked by a cloud of smoke surrounding them.

 

Suspect Nguyen Chunsheng (Lê Anh Thơ) purchased e-cigarettes and added drugs to them before selling them in the market. According to the Vietnamese Ministry of Health, the proportion of students and young people using e-cigarettes in Vietnam is increasing. However, both e-cigarettes and traditional cigarettes contain nicotine. E-cigarettes consist of low-temperature e-liquid, with approximately 16,000 flavorings available to choose from. Various components in these flavorings can have health implications and may potentially be mixed with other substances such as drugs and marijuana.

 

Due to the harm caused by e-cigarettes, the Ministry of Health has recommended banning this type of product in order to gradually reduce the supply and demand for tobacco. The ban on e-cigarettes is also aimed at protecting the health of the community, especially that of young people. As a result, the Drug Crime Investigation Bureau (C04, Ministry of Public Security) has successfully cracked a case involving an individual who was mixing drugs into e-cigarette vaporizer pens and advertising and selling them openly on social media, targeting students and college students directly.

 

In this case, C04 has filed charges and arrested Nguyen Chunsheng (28 years old, residing in Hoang Mai District, Hanoi) and five others to investigate their involvement in the illegal drug trade. Nguyen Chunsheng has been identified as the mastermind behind the operation. He learned the production methods online, purchased chemicals, aromatic chewing gum, synthetic marijuana, and e-cigarette devices from other countries, and brought them back to Hanoi. He hired individuals to manufacture the drugs, injecting the drug-containing aromatic chewing gum into e-cigarettes and tobacco, and then designed his own trademarks and packaging.

 

Deputy Director C04 has stated that the reason e-cigarettes and similar items attract teenagers is due to their bright colors and appealing flavors. Specifically, they target children between the ages of 12 and 13, in the 2nd and 3rd grade. Children of this age range are naturally curious, eager to explore, and have a desire to showcase their individuality. Major General Ruan Mingguang added, "The Criminal Forensic Institute has conducted a review and found five types of drugs, mostly marijuana e-liquid, ketamine, and methamphetamine.

 

Brigadier General Ruan Mingguang has stated that individuals who use these drugs will experience neurological excitation, hallucinations, and may even die from poisoning. In line with their assigned duties and tasks, Bureau C04 continues to crackdown on various disguised drug production lines, including e-cigarettes. Additionally, they have joined forces with the Ministry of Education to organize awareness campaigns in schools.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Special Report | Vape bans and tougher rules: the South Caucasus takes different paths
Special Report | Vape bans and tougher rules: the South Caucasus takes different paths
Azerbaijan's sweeping e-cigarette ban has raised concerns over enforcement errors and the emergence of illicit sales, while neighboring Armenia is tightening technical rules and preparing higher excise taxes. Georgia, meanwhile, has resisted calls for broader vape restrictions and introduced preferential taxes for some domestically produced cigarettes. The divergent approaches across the South Caucasus highlight a regional policy dilemma: how to curb nicotine use and protect public health without encouraging black markets or creating unintended economic consequences for businesses and consumers.
Nov.03
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Special Report | How Capital Is Reassessing the Global Tobacco and Modern Nicotine Industry: Lessons from a New York Forum
Capital is reassessing the global tobacco and modern nicotine industry as heated tobacco, vaping and nicotine pouches reshape demand, profitability and regulation. At the 2026 New Approaches Summit in New York, investors and analysts examined whether smoke-free growth can sustain earnings, how regulation shapes startup value, and whether shareholder engagement can be more effective than divestment. The debate points to a broader shift: tobacco transition is increasingly becoming a capital-allocation, governance and valuation question.
Capital Markets
Oct.05
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
Huabao International Buys Indonesian HNB Manufacturer for RMB 90 Million, Adding OEM/ODM Capacity
Huabao International Buys Indonesian HNB Manufacturer for RMB 90 Million, Adding OEM/ODM Capacity
Huabao International Holdings Limited will acquire 100% of PT Broad Far Indonesia through two wholly owned subsidiaries for approximately RMB 90 million. The Indonesian company manufactures and sells heat-not-burn tobacco sticks and provides OEM/ODM services. The sellers are part of a related-party group controlled by Huabao International Chair and controlling shareholder Zhu Linyao. PT Broad Far Indonesia generated $4.37 million in revenue and $177,000 in profit after tax in the first half of 2026, while net assets stood at about $326,000 at June-end. An independent valuer assessed the company’s equity at approximately RMB 93.06 million. Following completion, the HNB manufacturing operation will be consolidated into Huabao International.
News
Sep.29 by 2Firsts Perspectives